Global CRISPR Technology Market


Product Code: GB02092R Industry: Region:

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. It is a component of bacterial immune systems that can cut DNA, and has been repurposed as a gene editing tool. CRISPR is important because it allows scientists to rewrite the genetic code in almost any organism. It is simpler, cheaper, and more precise than previous gene editing techniques. Moreover, it has a range of real-world applications, including curing genetic disease and creating drought-resistant crops. The global CRISPR technology market was estimated at USD 1,337 million in 2021 and is expected to hit USD 7,008 million by 2028, registering a CAGR of 26.7% from 2022 to 2028 as per the latest report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global CRISPR technology market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the CRISPR technology industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for CRISPR technology can be segmented by product: CRISPR products, CRISPR services. The CRISPR products segment held the largest revenue share in 2021. CRISPR technology market is further segmented by application: agricultural, biomedical, others. Among these, the biomedical segment was accounted for the highest revenue generator in 2021. Based on end user, the CRISPR technology market is segmented into: academic institutes and research centers, contract research organizations (CROs), pharmaceutical companies, biotechnology companies. On the basis of region, the CRISPR technology market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By product:
– CRISPR products
– CRISPR services

By application:
– agricultural
– biomedical
– others

By end user:
– academic institutes and research centers
– contract research organizations (CROs)
– pharmaceutical companies
– biotechnology companies

By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The CRISPR products market is further segmented into kits and enzymes, libraries, design tools, antibodies, others. Furthermore, the CRISPR services market has been categorized into gRNA design and vector construction, screening services, cell line engineering, others. The biomedical market is further divided into gene therapy, drug discovery, diagnostics.

The market research report covers the analysis of key stake holders of the global CRISPR technology market. Some of the leading players profiled in the report include Abcam, Inc., Agilent Technologies, Inc., Caribou Biosciences, Inc., Cellecta, Inc., CRISPR Therapeutics AG, Editas Medicine, Inc., GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Ltd., Integrated DNA Technologies, Inc. (Danaher Corporation), Intellia Therapeutics, Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs GmbH, OriGene Technologies Inc., Precision BioSciences, Inc., Synthego Corporation, Thermo Fisher Scientific Inc., ToolGen, Inc., Transposagen Biopharmaceuticals Inc., among others.

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global CRISPR technology market.
– To classify and forecast the global CRISPR technology market based on product, application, end user, region.
– To identify drivers and challenges for the global CRISPR technology market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global CRISPR technology market.
– To identify and analyze the profile of leading players operating in the global CRISPR technology market.

Why Choose This Report
– Gain a reliable outlook of the global CRISPR technology market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.

Global CRISPR Technology Market

Interested in this report? Get your FREE sample now!
Global CRISPR Technology Market - Report Scope


Base Year


Forecast Year


CAGR (2022-2028)




Key Players

Abcam Inc., Agilent Technologies Inc., Caribou Biosciences Inc., Cellecta Inc., CRISPR Therapeutics AG, Editas Medicine Inc., GeneCopoeia Inc., GenScript Biotech Corporation, Horizon Discovery Ltd., Integrated DNA Technologies Inc. (Danaher Corporation), Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs GmbH, OriGene Technologies Inc., Precision BioSciences Inc., Synthego Corporation, Thermo Fisher Scientific Inc., ToolGen Inc., Transposagen Biopharmaceuticals Inc.

Related Reports
Want to customize this report?
The present report possesses the flexibility to be tailored to your specific needs. Our team of analysts and industry experts will collaborate directly with you to gain a comprehensive understanding of your requirements.
Scroll to Top

Download Free Sample - Global CRISPR Technology Market

Please fill out our form and we will get back to you.